Matches in Nanopublications for { ?s ?p "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP150188.RAj1TjGxrHvkg8hN7zWOoATJD1ZVmySOTv2g85yA6K0wg130_assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150188.RAj1TjGxrHvkg8hN7zWOoATJD1ZVmySOTv2g85yA6K0wg130_provenance.
- NP174024.RAQByMn6ThN8TBeRpEBEATrURx8gyEfYXNbl-hUYUBvRk130_assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174024.RAQByMn6ThN8TBeRpEBEATrURx8gyEfYXNbl-hUYUBvRk130_provenance.
- NP150187.RA5yWNVm50wK8OVghHG1u4dLFBOQEAV40iNOAqBCviSkE130_assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP150187.RA5yWNVm50wK8OVghHG1u4dLFBOQEAV40iNOAqBCviSkE130_provenance.
- NP174025.RAFC-6GNo_Ki2zMBpCE-hTZerk5fJL5-WqBhU0Yg_SViY130_assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP174025.RAFC-6GNo_Ki2zMBpCE-hTZerk5fJL5-WqBhU0Yg_SViY130_provenance.
- NP809261.RAFoDf4gE49-3xK1Zh1f3C-u4Cex5PLmf_ewpOeDfRMgQ130_assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP809261.RAFoDf4gE49-3xK1Zh1f3C-u4Cex5PLmf_ewpOeDfRMgQ130_provenance.
- NP684332.RA5ReNGyto2UR3OZnR9bI4L5wehbcSgGx1daQA-uFuU00130_assertion description "[The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP684332.RA5ReNGyto2UR3OZnR9bI4L5wehbcSgGx1daQA-uFuU00130_provenance.